BLUE KNIGHT™, a collaboration between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), offers emerging life science companies an opportunity to join the JLABS incubator ecosystem with additional support from BARDA. BLUE KNIGHT™ companies, selected for their mutual alignment to Johnson & Johnson and BARDA areas of interest, may have an opportunity to receive additional support including fee assistance and mentorship. At JLABS @ Washington, DC and other select JLABS sites, BLUE KNIGHT™ companies will join the full breadth of Johnson & Johnson Innovation, including opportunities for funding, third-party services, educational events and access to R&D experts from medical technology, consumer healthcare product and Janssen pharmaceutical teams.
About Blue Knight
Johnson & Johnson Innovation – JLABS is collaborating with the Biomedical Advanced Research and Development Authority (BARDA), a component of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, to form Blue Knight.
This collaboration aims to stimulate innovation and incubation of technologies that improve health security and response through companies focused on public health threats and emerging infectious diseases. Find out more about BARDA and its mission at www.PHE.gov/BARDA.
If you are looking to learn more about the Johnson & Johnson Innovation – JLABS model, JLABS @ Washington, DC, BLUE KNIGHT™, mutual areas of interest between Johnson & Johnson and BARDA, and what the application process entails, join us for our Informational Session! We are currently accepting applications.